Analyst Price Target is $50.00
▲ +38.89% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Schrödinger in the last 3 months. The average price target is $50.00, with a high forecast of $78.00 and a low forecast of $23.00. The average price target represents a 38.89% upside from the last price of $36.00.
Current Consensus is
The current consensus among 5 polled investment analysts is to buy stock in Schrödinger. This Buy consensus rating has held steady for over two years.
Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.